Mitogen-activated protein kinases and NFκB are involved in SP-A-enhanced responses of macrophages to mycobacteria

Respiratory Research

Volumn 10, Issue , 2009, Pages

  Lopez, Joseph P ^b   Vigerust, David J ^b   Shepherd, Virginia L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBIMYCIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTACYSTIN; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; SURFACTANT PROTEIN A; BENZOQUINONE DERIVATIVE; ENZYME INHIBITOR; HERBIMYCIN; MACROCYCLIC LACTAM;

ANIMAL CELL; ARTICLE; BIOCHEMISTRY; BONE MARROW; CELL MATURATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; IMMUNOBLOTTING; LUNG ALVEOLUS PROTEINOSIS; MACROPHAGE; MYCOBACTERIUM; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; DRUG ANTAGONISM; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; HUMAN; IMMUNOPRECIPITATION; MOUSE; MYCOBACTERIUM BOVIS; PHAGOCYTOSIS; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BENZOQUINONES; BLOTTING, WESTERN; BONE MARROW CELLS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOPRECIPITATION; LACTAMS, MACROCYCLIC; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYCOBACTERIUM BOVIS; NF-KAPPA B; NITRIC OXIDE; PHAGOCYTOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70249133712     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-10-60     Document Type: Article

References (66)

1. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. Jama 1995, 273(3):220-226. 10.1001/jama.273.3.220, 7807661.
2. Houben EN, Nguyen L, Pieters J. Interaction of pathogenic mycobacteria with the host immune system. Curr Opin Microbiol. 2006, 9(1):I76-185. 10.1016/j.mib.2005.12.014.
3. Pieters J, Gatfield J. Hijacking the host: survival of pathogenic mycobacteria inside macrophages. Trends Microbiol 2002, 10(3):142-146. 10.1016/S0966-842X(02)02305-3, 11864824.
4. Clemens DL, Horwitz MA. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J Exp Med 1995, 181(1):257-270. 2191842, 7807006, 10.1084/jem.181.1.257.
5. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, Fok AK, Allen RD, Gluck SL, Heuser J, Russell DG. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994, 263(5147):678-681. 10.1126/science.8303277, 8303277.
6. Kelley VA, Schorey JS. Mycobacterium's arrest of phagosome maturation in macrophages requires Rab5 activity and accessibility to iron. Mol Biol Cell 2003, 14(8):3366-3377. 181573, 12925769, 10.1091/mbc.E02-12-0780.
7. Vergne I, Chua J, Lee HH, Lucas M, Belisle J, Deretic V. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2005, 102(11):4033-4038. 554822, 15753315, 10.1073/pnas.0409716102.
8. Roach SK, Schorey JS. Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria. Infect Immun 2002, 70(6):3040-3052. 128028, 12010996, 10.1128/IAI.70.6.3040-3052.2002.
9. Correll PH, Morrison AC, Lutz MA. Receptor tyrosine kinases and the regulation of macrophage activation. J Leukoc Biol 2004, 75(5):731-737. 10.1189/jlb.0703347, 14726496.
10. Romashkova JA, Makarov SS. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401(6748):86-90. 10.1038/43474, 10485711.
11. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS, Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2000, 20(5):1626-1638. 85346, 10669740, 10.1128/MCB.20.5.1626-1638.2000.
12. Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol 1999, 71(3-4):479-500. 10.1016/S0079-6107(98)00056-X, 10354710.
13. Rao KM. MAP kinase activation in macrophages. J Leukoc Biol 2001, 69(1):3-10.
14. Procyk KJ, Kovarik P, von Gabain A, Baccarini M. Salmonella typhimurium and lipopolysaccharide stimulate extracellularly regulated kinase activation in macrophages by a mechanism involving phosphatidylinositol 3-kinase and phospholipase D as novel intermediates. Infect Immun 1999, 67(3):1011-1017. 96423, 10024537.
15. Mancuso G, Midiri A, Beninati C, Piraino G, Valenti A, Nicocia G, Teti D, Cook J, Teti G. Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci. J Immunol 2002, 169(3):1401-1409.
16. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 2001, 98(5):1429-1439. 10.1182/blood.V98.5.1429, 11520792.
17. Schorey JS, Cooper AM. Macrophage signalling upon mycobacterial infection: the MAP kinases lead the way. Cell Microbiol 2003, 5(3):133-142. 10.1046/j.1462-5822.2003.00263.x, 12614457.
18. Chan ED, Morris KR, Belisle JT, Hill P, Remigio LK, Brennan PJ, Riches DW. Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. Infect Immun 2001, 69(4):2001-2010. 98123, 11254551, 10.1128/IAI.69.4.2001-2010.2001.
19. Bhattacharyya A, Pathak S, Kundu M, Basu J. Mitogen-activated protein kinases regulate Mycobacterium avium-induced tumor necrosis factor-alpha release from macrophages. FEMS Immunol Med Microbiol 2002, 34(1):73-80.
20. Reiling N, Blumenthal A, Flad HD, Ernst M, Ehlers S. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J Immunol 2001, 167(6):3339-3345.
21. Ibata-Ombetta S, Jouault T, Trinel PA, Poulain D. Role of extracellular signal-regulated protein kinase cascade in macrophage killing of Candida albicans. J Leukoc Biol 2001, 70(1):149-154.
22. Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 1999, 285(5435):1920-1923. 10.1126/science.285.5435.1920, 10489373.
23. Prive C, Descoteaux A. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur J Immunol 2000, 30(8):2235-2244. 10.1002/1521-4141(2000)30:8<2235::AID-IMMU2235>3.0.CO;2-9, 10940915.
24. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260. 10.1146/annurev.immunol.16.1.225, 9597130.
25. Yamada H, Mizuno S, Reza-Gholizadeh M, Sugawara I. Relative importance of NF-kappaB p50 in mycobacterial infection. Infect Immun 2001, 69(11):7100-7105. 100095, 11598086, 10.1128/IAI.69.11.7100-7105.2001.
26. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999, 163(7):3920-3927.
27. Means TK, Jones BW, Schromm AB, Shurtleff BA, Smith JA, Keane J, Golenbock DT, Vogel SN, Fenton MJ. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 2001, 166(6):4074-4082.
28. Ameixa C, Friedland JS. Interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes is regulated by protein tyrosine kinases but not by ERK1/2 or p38 mitogen-activated protein kinases. Infect Immun 2002, 70(8):4743-4746. 128139, 12117995, 10.1128/IAI.70.8.4743-4746.2002.
29. Toossi Z, Hamilton BD, Phillips MH, Averill LE, Ellner JJ, Salvekar A. Regulation of nuclear factor-kappa B and its inhibitor I kappa B-alpha/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. J Immunol 1997, 159(8):4109-4116.
30. Shepherd VL, Lopez JP. The role of surfactant-associated protein A in pulmonary host defense. Immunol Res 2001, 23(2-3):111-120. 10.1385/IR:23:2-3:111, 11444377.
31. Weikert LF, Edwards K, Chroneos ZC, Hager C, Hoffman L, Shepherd VL. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor. Am J Physiol 1997, 272(5 Pt 1):L989-995.
32. Pasula R, Downing JF, Wright JR, Kachel DL, Davis TE, Martin WJ. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am J Respir Cell Mol Biol 1997, 17(2):209-217.
33. Hawgood S, Brown C, Edmondson J, Stumbaugh A, Allen L, Goerke J, Clark H, Poulain F. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol 2004, 78(16):8565-8572. 479098, 15280465, 10.1128/JVI.78.16.8565-8572.2004.
34. Hartshorn KL, Crouch E, White MR, Colamussi ML, Kakkanatt A, Tauber B, Shepherd V, Sastry KN. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 1998, 274(6 Pt 1):L958-969.
35. Tino MJ, Wright JR. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 1996, 270(4 Pt 1):L677-688.
36. Geertsma MF, Nibbering PH, Haagsman HP, Daha MR, van Furth R. Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. Am J Physiol 1994, 267(5 Pt 1):L578-584.
37. McNeely TB, Coonrod JD. Comparison of the opsonic activity of human surfactant protein A for Staphylococcus aureus and Streptococcus pneumoniae with rabbit and human macrophages. J Infect Dis 1993, 167(1):91-97.
38. Hickman-Davis JM, Lindsey JR, Zhu S, Matalon S. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages. Am J Physiol 1998, 274(2 Pt 1):L270-277.
39. Kabha K, Schmegner J, Keisari Y, Parolis H, Schlepper-Schaeffer J, Ofek I. SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol 1997, 272(2 Pt 1):L344-352.
40. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997, 158(9):4336-4340.
41. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998, 19(4):700-708.
42. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999, 103(7):1015-1021. 408263, 10194474, 10.1172/JCI5849.
43. Hickman-Davis JM, Gibbs-Erwin J, Lindsey JR, Matalon S. Role of surfactant protein-A in nitric oxide production and mycoplasma killing in congenic C57BL/6 mice. Am J Respir Cell Mol Biol 2004, 30(3):319-325. 10.1165/rcmb.2003-0246OC, 12959946.
44. Weikert LF, Lopez JP, Abdolrasulnia R, Chroneos ZC, Shepherd VL. Surfactant protein A enhances mycobacterial killing by rat macrophages through a nitric oxide-dependent pathway. Am J Physiol Lung Cell Mol Physiol 2000, 279(2):L216-223.
45. Blackwell TS, Yull FE, Chen CL, Venkatakrishnan A, Blackwell TR, Hicks DJ, Lancaster LH, Christman JW, Kerr LD. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 2000, 162(3 Pt 1):1095-1101.
46. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992, 175(4):1111-1122. 2119182, 1552282, 10.1084/jem.175.4.1111.
47. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM, Billiar TR, Geller DA. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 1998, 273(24):15148-15156. 10.1074/jbc.273.24.15148, 9614127.
48. Somogyi PA, Foldes I. Incorporation of thymine, thymidine, adenine and uracil into nucleic acids of Mycobacterium phlei and its phage. Ann Microbiol (Paris) 1983, 134A(1):19-28.
49. Aston C, Rom WN, Talbot AT, Reibman J. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. Am J Respir Crit Care Med 1998, 157(6 Pt 1):1943-1950.
50. Fenteany G, Schreiber SL. Lactacystin, proteasome function, and cell fate. J Biol Chem 1998, 273(15):8545-8548. 10.1074/jbc.273.15.8545, 9535824.
51. Blumenthal A, Ehlers S, Ernst M, Flad HD, Reiling N. Control of mycobacterial replication in human macrophages: roles of extracellular signal-regulated kinases 1 and 2 and p38 mitogen-activated protein kinase pathways. Infect Immun 2002, 70(9):4961-4967. 128221, 12183542, 10.1128/IAI.70.9.4961-4967.2002.
52. Tse HM, Josephy SI, Chan ED, Fouts D, Cooper AM. Activation of the mitogen-activated protein kinase signaling pathway is instrumental in determining the ability of Mycobacterium avium to grow in murine macrophages. J Immunol 2002, 168(2):825-833.
53. Forget G, Matte C, Siminovitch KA, Rivest S, Pouliot P, Olivier M. Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1. Eur J Immunol 2005, 35(6):1906-1917. 10.1002/eji.200526037, 15902687.
54. Henning LN, Azad AK, Parsa KV, Crowther JE, Tridandapani S, Schlesinger LS. Pulmonary surfactant protein A regulates TLR expression and activity in human macrophages. J Immunol 2008, 180(12):7847-7858. 2562757, 18523248.
55. Carter AB, Knudtson KL, Monick MM, Hunninghake GW. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 1999, 274(43):30858-30863. 10.1074/jbc.274.43.30858, 10521478.
56. Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, Schlesinger LS. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 2002, 169(7):3565-3573.
57. Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 2002, 4(9):937-944. 10.1016/S1286-4579(02)01611-8, 12106786.
58. Murakami S, Iwaki D, Mitsuzawa H, Sano H, Takahashi H, Voelker DR, Akino T, Kuroki Y. Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2. J Biol Chem 2002, 277(9):6830-6837. 10.1074/jbc.M106671200, 11724772.
59. Chroneos ZC, Abdolrasulnia R, Whitsett JA, Rice WR, Shepherd VL. Purification of a cell-surface receptor for surfactant protein A. J Biol Chem 1996, 271(27):16375-16383. 10.1074/jbc.271.27.16375, 8663107.
60. van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, van Golde LM. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990, 2(1):91-98.
61. Weissbach S, Neuendank A, Pettersson M, Schaberg T, Pison U. Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages. Am J Physiol 1994, 267(6 Pt 1):L660-666.
62. Koptides M, Umstead TM, Floros J, Phelps DS. Surfactant protein A activates NF-kappa B in the THP-1 monocytic cell line. Am J Physiol 1997, 273(2 Pt 1):L382-388.
63. Blau H, Riklis S, Van Iwaarden JF, McCormack FX, Kalina M. Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A. Am J Physiol 1997, 272(6 Pt 1):L1198-1204.
64. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, Si-Tahar M. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002, 168(12):5989-5992.
65. Vazquez de Lara LG, Umstead TM, Davis SE, Phelps DS. Surfactant protein A increases matrix metalloproteinase-9 production by THP-1 cells. Am J Physiol Lung Cell Mol Physiol 2003, 285(4):L899-906.
66. Gomes MS, Florido M, Pais TF, Appelberg R. Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J Immunol 1999, 162(11):6734-6739.